Therapeutic Efficacy of Small Extracellular Vesicles Loaded with ROCK Inhibitor in Parkinson’s Disease
<b>Background/Objectives:</b> Parkinson’s disease (PD) is a rapidly growing neurological disorder in the developed world, affecting millions over the age of 60. The decline in motor functions occurs due to a progressive loss of midbrain dopaminergic neurons, resulting in lowered dopamine...
Saved in:
| Main Authors: | Candy Carbajal, Myosotys Rodriguez, Florida Owens, Nicole Stone, Dileepkumar Veeragoni, Rebecca Z. Fan, Kim Tieu, Nazira El-Hage |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/3/365 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury
by: Weihang Zhou, et al.
Published: (2024-12-01) -
Milk-derived extracellular vesicles: nature’s nanocarriers for drug delivery and therapeutics
by: Chen Kong, et al.
Published: (2025-08-01) -
Extracellular vesicles: Function, resilience, biomarker, bioengineering, and clinical implications
by: Der-Shan Sun, et al.
Published: (2024-05-01) -
Recent Advances in Cancer Cell Membrane‐Based Nanoparticles and Cancer Cell‐Derived Small Extracellular Vesicles as Drug Delivery Platforms
by: Wei Zhang, et al.
Published: (2025-06-01) -
STING Agonist Drug Delivery by Bacterial Extracellular Vesicles Induces Synergistic Immuno‐Oncology Responses and Efficient Inhibition of Tumour Growth
by: Jan Lötvall, et al.
Published: (2025-07-01)